Article: Exploration of Novel Urolithin C Derivatives as Non-Competitive Inhibitors of Liver Pyruvate Kinase.
Pharmaceuticals (Basel, Switzerland)
2023 Volume 16, Issue 5
Abstract: ... to cirrhosis. Recently, urolithin C has been reported as a new scaffold for the development of allosteric ... of urolithin C was carried out. More than 50 analogues were synthesized and tested regarding the chemical ...
Abstract | The inhibition of liver pyruvate kinase could be beneficial to halt or reverse non-alcoholic fatty liver disease (NAFLD), a progressive accumulation of fat in the liver that can lead eventually to cirrhosis. Recently, urolithin C has been reported as a new scaffold for the development of allosteric inhibitors of liver pyruvate kinase (PKL). In this work, a comprehensive structure-activity analysis of urolithin C was carried out. More than 50 analogues were synthesized and tested regarding the chemical features responsible for the desired activity. These data could pave the way to the development of more potent and selective PKL allosteric inhibitors. |
---|---|
Language | English |
Publishing date | 2023-04-28 |
Publishing country | Switzerland |
Document type | Journal Article |
ZDB-ID | 2193542-7 |
ISSN | 1424-8247 |
ISSN | 1424-8247 |
DOI | 10.3390/ph16050668 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.